In the European Randomised Study of Screening for Prostate Cancer (ERSPC) trial, PCA3 was assessed as a first line-screening test. 40 While the positive predictive values of a PCA3 score of 10 or ...

The clinical study leading to FDA approval of the PCA3 test in February of 2012 was a multicenter study from 14 clinical sites. The study included 466 men aged 50 years or older who had at least one ...

WASHINGTON, June 1 (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday. They said ...

May 12, 2008 — The urine test for the PCA3 gene, already marketed for use in diagnosing prostate cancer, could also be useful in prognostication. It might have clinical application in selecting men ...

“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively” Researchers, led by first author Parisa Najari and corresponding author Reza Safaralizadeh ...

WASHINGTON (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday. They said Gen-Probe's ...